People: Implant Sciences Corp (IMSC.PK)
IMSC.PK on OTC Markets Group
1.06USD
21 May 2013
1.06USD
21 May 2013
Price Change (% chg)
$0.12 (+12.89%)
$0.12 (+12.89%)
Prev Close
$0.94
$0.94
Open
$0.93
$0.93
Day's High
$1.08
$1.08
Day's Low
$0.91
$0.91
Volume
640,341
640,341
Avg. Vol
248,554
248,554
52-wk High
$1.84
$1.84
52-wk Low
$0.75
$0.75
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Glenn Bolduc |
60 | 2010 | Chairman of the Board, President, Chief Executive Officer |
Roger Deschenes |
54 | 2010 | Chief Financial Officer, Vice President - Finance |
William McGann |
54 | 2012 | Chief Operating Officer, Director |
Darryl Jones |
54 | 2012 | Vice President - Sales and Marketing |
Brenda Baron |
50 | 2009 | Vice President - Manufacturing and Technical Services |
Todd Silvestri |
46 | 2008 | Vice President - Advanced Technology and Product Development |
John Keating |
59 | 2009 | Director |
Robert Liscouski |
58 | 2009 | Independent Director |
Howard Safir |
71 | 2009 | Independent Director |
Michael Turmelle |
53 | 2005 | Independent Director |
Biographies
| Name | Description |
|---|---|
Glenn Bolduc |
Mr. Glenn D. Bolduc is Chairman of the Board, President, Chief Executive Officer of Implant Sciences Corporation. He has served as Chairman of the Board since May 2009 and as President and Chief Executive Officer since January 2009, having joined the Company as Chief Financial Officer in July 2008. Prior to joining the Company, Mr. Bolduc served as acting CEO and CFO of Horizon’s Edge Casino Cruises, LLC. From January 2001 through January 2006 Mr. Bolduc was the principal of Radius Ventures LLC, a strategic advisory firm. Prior to Radius Ventures, Mr. Bolduc has held executive management and financial positions, including CEO and CFO, with several venture-backed and publicly-held companies in various technology industries. From 1996 to 1999, Mr. Bolduc served as President and Chief Executive Officer of Vialog Corporation, a publicly-held provider of teleconferencing and other group communications services. Mr. Bolduc received his undergraduate degree in accounting from Fairleigh Dickinson University and began his accounting career with PricewaterhouseCoopers. |
Roger Deschenes |
Mr. Roger P. Deschenes is Chief Financial Officer, Vice President - Finance of Implant Sciences Corp. He joined the Company in June 2008 as Controller, was promoted to Vice President, Finance in January 2009 and to Chief Financial Officer in July 2010. Mr. Deschenes has more than 25 years of accounting and financial leadership experience with publicly traded and private companies. Prior to joining Implant Sciences, Mr. Deschenes served as Vice President, Finance with Beacon Roofing Supply, Inc. from 2006 to 2007. From 1990 to 2006, Mr. Deschenes served in several senior accounting and financial capacities at Saucony, Inc. including: Vice President, Controller, Chief Accounting Officer and Assistant Treasurer. Mr. Deschenes received a B.S. in Business Administration from Salem State University and is a Certified Management Accountant. |
William McGann |
Dr. William J. McGann, Ph.D., has been appointed as Chief Operating Officer, Director of Implant Sciences Corp., effective April 2, 2012. Dr. McGann had served as a strategic advisor to Glenn D. Bolduc, Chief Executive Officer of the Company since April 2011. Prior to his appointment as Chief Operating Officer of the Company, from March 2010 to the present, Dr. McGann served as Vice President, Engineering, Global Fire Products, UTC Fire and Security, a business unit of United Technologies Corporation. From January 2005 through March 2010, Dr. McGann served as Vice-President, Research and Development at GE Ion Track and was promoted to Chief Technology Officer of GE Security. From January 1991 through January 2005, Dr. McGann served as Vice President, Research and Development and was one of the founders of Ion Track Instruments, where he played a key role in creating an industry around explosives trace detection (ETD) science and technology. Ion Track was sold to General Electric in 2005. Dr. McGann holds a Ph.D. in Physical Chemistry from the University of Connecticut, where his doctoral work was in the area of Magnetic Resonance and Laser Spectroscopy. |
Darryl Jones |
Dr. Darryl K. Jones has been appointed as Vice President - Sales and Marketing of Implant Sciences Corp., effective May 09, 2012. From 2009 until he joined the Company, Dr. Jones served as Vice President, Global Product Management at Morpho Detection, Inc., a business unit of the Safran Group. From 2006 through 2009, Dr. Jones served as General Manager, Global Security Sales at GE Security and served as Global Business Manager at GE Healthcare from 2003 through 2006. Dr. Jones holds a Ph.D. in Optical Science and Engineering from the University of Alabama in Huntsville, a Masters of Arts in Physics and Bachelor of Arts from Fisk University. |
Brenda Baron |
Ms. Brenda L. Baron is Vice President - Manufacturing and Technical Services of Implant Sciences Corp., since February, 2009. Ms. Baron joined the company in April 2004. Ms. Baron developed the Security Division's manufacturing operations, as well as manufacturing, test, and documentation control. Prior to joining the Company, Ms. Baron served as Documentation Engineer with the instrumentation division of Millipore Corporation, from 2002 to 2004, and was employed at Ion Track Instruments, an explosives trace detector manufacturer as Configuration Manager, from 1998 to 2001, where she played a key role in bringing handheld, bench top, and portal trace detectors into production. |
Todd Silvestri |
Mr. Todd A. Silvestri is Vice President - Advanced Technology and Product Development of Implant Sciences Corp. Mr. Silvestri joined the company in September 2008 and is directly responsible for the design and commercialization of the Company’s advanced explosive trace detection solutions. Previously, Mr. Silvestri was Senior Vice President of Century Capital Partners, assisting his clients in defining optimal exiting strategies, securing capital, and expanding into foreign markets. Prior to that, he led New Product Development for Environmental Systems Products (ESP), where he was responsible for expanding the company’s traditional business-to-government services into new frontiers by commercializing products and services for private business clients and consumers. In 2003, Mr. Silvestri founded APAC Global LLC providing consulting in the areas of company establishment, localization/relocation of operations, supply chain management, and organizational design primarily focused with small to medium sized companies expanding to, or within, the Asia Pacific Region. Mr. Silvestri holds an M.B.A. from the Kellogg School of Management at Northwestern University, as well as a B.S. in Chemical Engineering from Clarkson University. |
John Keating |
Mr. John A. Keating is Director of Implant Sciences Corp., since May 2009. Mr. Keating has been an independent consultant since April 2012, prior to which time he served as the Vice President of Global Customer Fulfillment for the Timberland Company, a premium global footwear brand. Mr. Keating was responsible for all transportation, distribution, customs, and order management. In addition, Mr. Keating oversaw North American customer service and apparel sourcing operations. Mr. Keating holds a B.A. degree from Bridgewater State University and an M.B.A. from Suffolk University. |
Robert Liscouski |
Mr. Robert P. Liscouski is an Independent Director of Implant Sciences Corp., since May 2009. Since July 2009, Mr. Liscouski has been a partner at Secure Strategy Group, a homeland security-focused banking and strategic advisory firm. Mr. Liscouski was the first Assistant Secretary for Infrastructure Protection for the Department of Homeland Security, serving from March 2003 to February 2005. Mr. Liscouski’s private sector experience includes serving as the CEO of Content Analyst, as Director of Information Assurance for The Coca-Cola Company and Vice President, Law Enforcement Division, for ORION Scientific Systems. Mr. Liscouski’s government experience includes 11 years as a Special Agent with the Diplomatic Security Service of the U.S. Department of State with assignments including being the State Department representative to INTERPOL, Mobile Training Team Leader, Beirut and Rome, and five years with the Bergen County, NJ, Prosecutor’s Office as an undercover and homicide investigator. Mr. Liscouski is a Senior Fellow at the Center of Strategic and International Studies in Washington, D.C. and served for 12 years as an advisor to the U.S. government on technology matters. Mr. Liscouski holds a B.S. degree in Criminal Justice from John Jay College of Criminal Justice and a Masters of Public Administration from the Kennedy School of Government, Harvard University. |
Howard Safir |
Mr. Howard Safir is an Independent Director of Implant Sciences Corp., since May 2009. Mr. Safir has served as Chief Executive Officer of the security consulting and investigations unit of GlobalOptions Group, Inc., since May 2006 and as Chairman, Chief Executive Officer and Principal of the November Group a company that provides strategic advisory and customer acquisition services to companies in the security, law enforcement, intelligence and defense industries. Mr. Safir was the founder, Chairman and Chief Executive Officer of SafirRosetti, LLC, a premier security consulting company, from December 2001 until its acquisition in May 2006 by GlobalOptions Group, Inc. In 1996, Mr. Safir was appointed the 39th Police Commissioner of the City of New York by Mayor Rudolph W. Giuliani, after serving as New York City’s 29th Fire Commissioner for the prior two years, making him the only individual in the history of New York City to serve as both police and fire commissioner. Mr. Safir currently serves as a director of Verint Systems, Inc. and LexisNexis Special Services, Inc., a private company. From February 2004 to October 2006, Mr. Safir served as Chairman of the Board of Directors of GVI Security Solutions, Inc., a provider of video surveillance and security solutions products and from June 2005 to July 2006 served as a director of Blastgard International, Inc., a developer and designer of proprietary blast mitigation materials, both of which are public companies. Mr. Safir received his B.A. in History and Political Science from Hofstra University in 1963. He attended Harvard University's John F. Kennedy School of Government, receiving certificates in the programs for Senior Managers in Government in 1988 and for National and International Security in 1989. Mr. Safir is a member of the Board of Trustees of Hofstra University and a director of the foundation of the International Association of Chiefs of Police. |
Michael Turmelle |
Mr. Michael C. Turmelle is an Independent Director of Implant Sciences Corp., since December 2005. Since November 2007, Mr. Turmelle has served as the Principle of SFTT Consulting, assisting companies in the renewable energy, medical devices and security markets with financial, strategic, and operational issues. From 1987 until October 2007, Mr. Turmelle worked for SatCon Technology Corporation, holding several positions including Chief Financial Officer from 1991 until 2000 and Chief Operating Officer from 2000 to 2005. Mr. Turmelle holds a B.A. degree in Economics from Amherst College and a Financial Management Program certificate from General Electric. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Glenn Bolduc |
571,144 |
Roger Deschenes |
289,987 |
William McGann |
-- |
Darryl Jones |
-- |
Brenda Baron |
237,804 |
Todd Silvestri |
212,734 |
John Keating |
-- |
Robert Liscouski |
-- |
Howard Safir |
-- |
Michael Turmelle |
-- |
As Of 29 Jun 2012
Options Compensation
| Name | Options | Value |
|---|---|---|
Glenn Bolduc |
0 | 0 |
Roger Deschenes |
0 | 0 |
William McGann |
0 | 0 |
Darryl Jones |
0 | 0 |
Brenda Baron |
0 | 0 |
Todd Silvestri |
0 | 0 |
John Keating |
0 | 0 |
Robert Liscouski |
0 | 0 |
Howard Safir |
0 | 0 |
Michael Turmelle |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
BOLDUC GLENN D |
10,000 | $0.00 |
BOLDUC GLENN D |
10,000 | $0.00 |
BOLDUC GLENN D |
40,000 | $0.17 |
BOLDUC GLENN D |
5,000 | $0.00 |
BOLDUC GLENN D |
10,000 | $0.00 |
BOLDUC GLENN D |
10,000 | $0.00 |
BOLDUC GLENN D |
10,000 | $0.00 |
BOLDUC GLENN D |
10,000 | $0.00 |
BOLDUC GLENN D |
250,000 | $0.17 |
BOLDUC GLENN D |
5,000 | $0.00 |
BOLDUC GLENN D |
10,000 | $0.00 |
BOLDUC GLENN D |
5,000 | $0.00 |
BOLDUC GLENN D |
5,000 | $0.00 |
BOLDUC GLENN D |
10,000 | $0.00 |
KEATING JOHN |
200,000 | $0.08 |
TURMELLE MICHAEL C |
100,000 | $0.17 |
TURMELLE MICHAEL C |
10,000 | $0.20 |
TURMELLE MICHAEL C |
20,000 | $0.20 |
BOLDUC GLENN D |
26,400 | $0.20 |
BOLDUC GLENN D |
103,600 | $0.17 |
DESCHENES ROGER P |
100,000 | $0.10 |
BOLDUC GLENN D |
10,900 | $0.00 |
DESCHENES ROGER P |
75,000 | $0.17 |
BOLDUC GLENN D |
10,900 | $0.00 |
DESCHENES ROGER P |
25,000 | $0.20 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
